Crystallization is a major technological process for particle formation in
pharmaceutical industry and, in addition, plays an important role in defini
ng the stability and drug release properties of the final dosage forms. Ind
ustrial and regulatory aspects of crystallization are briefly reviewed with
reference to solid-state properties of pharmaceuticals. Crystallization, i
ncorporating wider definition to include precipitation and solid-state tran
sitions, is considered in terms of preparation of materials for direct comp
ression, formation of amorphous, solvated and polymorphic forms. chiral sep
aration of drugs, production of materials for inhalation drug delivery and
injections. Finally, recent developments in supercritical fluid particle te
chnology is considered in relationship to the areas discussed. (C) 2000 Els
evier Science B.V. All rights reserved.